Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/05/08/2663841/0/en/TCR-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2023/04/03/2640162/0/en/TCR-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2023/03/23/2632946/0/en/TCR-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2023/03/06/2620800/0/en/Adaptimmune-and-TCR-Therapeutics-Announce-Strategic-Combination-to-Create-a-Preeminent-Cell-Therapy-Company-for-Solid-Tumors.html
https://www.globenewswire.com/news-release/2023/02/08/2603758/0/en/TCR-Therapeutics-to-Present-at-SVB-Securities-Global-Biopharma-Conference-2023.html
https://www.fiercebiotech.com/biotech/scoop-tcr2-therapeutics-just-laid-40-its-staff-its-second-round-cuts-less-six-months
https://www.globenewswire.com//news-release/2023/01/05/2584129/0/en/TCR-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com//news-release/2023/01/05/2583769/0/en/TCR-Therapeutics-Announces-Pipeline-Priorities-for-2023.html
https://www.globenewswire.com//news-release/2022/12/01/2566340/0/en/TCR-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com//news-release/2022/11/23/2561475/0/en/TCR-Therapeutics-to-Present-at-the-Piper-Sandler-Healthcare-Conference.html